• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受肝素诱导的体外低密度脂蛋白沉淀(HELP)治疗的患者中,血液流变学改善与血浆纤维蛋白原和低密度脂蛋白降低有关。

Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).

作者信息

Schuff-Werner P, Schütz E, Seyde W C, Eisenhauer T, Janning G, Armstrong V W, Seidel D

机构信息

Department of Clinical Chemistry, University Clinics, Goettingen, FRG.

出版信息

Eur J Clin Invest. 1989 Feb;19(1):30-7. doi: 10.1111/j.1365-2362.1989.tb00192.x.

DOI:10.1111/j.1365-2362.1989.tb00192.x
PMID:2499459
Abstract

Heparin-induced Extracorporeal LDL-Precipitation (HELP) is an effective procedure for the elimination of both plasma LDL and fibrinogen. In 10 adult patients with severe type II hyperlipoproteinemia, a single HELP treatment of 3 1 plasma led to an acute decrease in the average plasma viscosity (PV) from 1.30 to 1.1 mPas. At the same time, an even more marked decrease in the mean erythrocyte aggregation rate from a pathological value of 7.9% to a value of 3.7% (normal range less than 5%) was observed. Long-term studies on five patients demonstrated a lasting improvement in these two haemorheological variables. The acute rheological changes were also accompanied by an improvement in polarographically determined muscle oxygen tension. Mean oxygen tension values measured in both the m.biceps brachii and the m.tibialis anterior in five patients before and after a single HELP treatment increased from 30 +/- 4 to 37 +/- 7 mmHg and from 27 +/- 2 to 31 +/- 3 mmHg respectively. These results may provide an explanation for the rapid improvement in patients' clinical symptoms such as angina pectoris and in stress electrocardiogram which have been observed during HELP therapy.

摘要

肝素诱导的体外低密度脂蛋白沉淀法(HELP)是一种有效清除血浆低密度脂蛋白和纤维蛋白原的方法。在10例重度II型高脂蛋白血症成年患者中,单次进行3升血浆的HELP治疗可使平均血浆黏度(PV)从1.30毫帕秒急剧降至1.1毫帕秒。与此同时,观察到平均红细胞聚集率从病理值7.9%更显著地降至3.7%(正常范围小于5%)。对5例患者的长期研究表明,这两个血液流变学变量持续改善。急性流变学变化还伴随着极谱法测定的肌肉氧张力的改善。5例患者在单次HELP治疗前后,肱二头肌和胫前肌的平均氧张力值分别从30±4毫米汞柱增至37±7毫米汞柱以及从27±2毫米汞柱增至31±3毫米汞柱。这些结果或许可以解释在HELP治疗期间观察到的患者临床症状(如心绞痛)和应激心电图的快速改善。

相似文献

1
Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).在接受肝素诱导的体外低密度脂蛋白沉淀(HELP)治疗的患者中,血液流变学改善与血浆纤维蛋白原和低密度脂蛋白降低有关。
Eur J Clin Invest. 1989 Feb;19(1):30-7. doi: 10.1111/j.1365-2362.1989.tb00192.x.
2
[Acute effects of extracorporeal LDL cholesterol and fibrinogen elimination on blood rheology and microcirculation].[体外低密度脂蛋白胆固醇和纤维蛋白原清除对血液流变学和微循环的急性影响]
Dtsch Med Wochenschr. 1990 Jan 5;115(1):3-7. doi: 10.1055/s-2008-1060358.
3
[Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].[肝素诱导的体外低密度脂蛋白沉淀(HELP):脑血管疾病和外周动脉闭塞性疾病的一种新的治疗干预措施]
Wien Med Wochenschr. 1993;143(22):563-70.
4
Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemia.HELP-LDL 单采术联合 HMG-CoA 还原酶抑制剂用于最大限度治疗与严重高胆固醇血症相关的冠心病的长期临床经验。
ASAIO Trans. 1989 Jul-Sep;35(3):580-3. doi: 10.1097/00002480-198907000-00133.
5
In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation.血脂分离技术的体内流变学效应:硫酸葡聚糖低密度脂蛋白吸附与肝素诱导低密度脂蛋白沉淀的比较
ASAIO Trans. 1990 Jul-Sep;36(3):M327-30.
6
[Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
Z Kardiol. 1997;86 Suppl 1:57-64.
7
LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease.采用HELP系统进行低密度脂蛋白去除法:对重度高胆固醇血症缺血性心脏病患者的16个月研究
Beitr Infusionsther. 1988;23:146-51.
8
Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP).肝素诱导的体外低密度脂蛋白沉淀法(HELP)治疗重度高胆固醇血症
Beitr Infusionsther. 1988;23:118-26.
9
Effectiveness of long-term heparin-induced extracorporeal LDL precipitation (HELP) in improving coronary calcifications.长期肝素诱导的体外低密度脂蛋白沉淀(HELP)对改善冠状动脉钙化的有效性。
Int J Artif Organs. 2003 Mar;26(3):252-5. doi: 10.1177/039139880302600312.
10
Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system.通过在低pH值下沉淀选择性去除低密度脂蛋白(LDL):HELP系统的首次临床应用。
Klin Wochenschr. 1987 Feb 16;65(4):161-8. doi: 10.1007/BF01728226.

引用本文的文献

1
Heparin-Mediated Extracorporeal Low-Density Lipoprotein Precipitation Apheresis for Treating Peripheral Arterial Disease in Patients with Chronic Kidney Disease.肝素介导的体外低密度脂蛋白沉淀单采术治疗慢性肾脏病患者的外周动脉疾病
J Clin Med. 2024 Feb 16;13(4):1121. doi: 10.3390/jcm13041121.
2
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol.用内皮素拮抗剂治疗非动脉炎性前部缺血性视神经病变:ENDOTHELION(缺血性视神经病变中的内皮素拮抗剂受体)——一项多中心随机对照试验方案。
Trials. 2022 Oct 29;23(1):916. doi: 10.1186/s13063-022-06786-9.
3
LDL Apheresis and Lp (a) Apheresis: A Clinician's Perspective.
LDL 血浆吸附治疗和 Lp(a) 血浆吸附治疗:临床医生视角。
Curr Atheroscler Rep. 2021 Feb 17;23(4):15. doi: 10.1007/s11883-021-00911-w.
4
Two Patients with Familial Hypercholesterolemia Who Were Successfully Weaned from Low-density Lipoprotein Apheresis after Treatment with Evolocumab.两名家族性高胆固醇血症患者在接受依洛尤单抗治疗后成功停用低密度脂蛋白分离术。
Intern Med. 2017;56(12):1531-1535. doi: 10.2169/internalmedicine.56.7958. Epub 2017 Jun 15.
5
Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by in vivo high-resolution CMR--a comparative analysis.采用体内高分辨率 CMR 评估慢性脂质吸附治疗患者颈动脉粥样硬化斑块的特征——一项对比分析。
J Cardiovasc Magn Reson. 2012 Nov 29;14(1):80. doi: 10.1186/1532-429X-14-80.
6
Role of lipid apheresis in changing times.血脂分离术在时代变迁中的作用。
Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):7-14. doi: 10.1007/s11789-012-0049-3.
7
Lipid apheresis: oxidative stress, rheology, and vasodilatation.血脂分离术:氧化应激、流变学与血管舒张
Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):45-9. doi: 10.1007/s11789-012-0043-9.
8
[Rheological determinants of end-organ damage].
Internist (Berl). 2003 Jul;44(7):853-63. doi: 10.1007/s00108-003-0949-x.
9
[Coronary heart disease in childhood in familial hypercholesteremia. Maximum therapy with LDL apheresis].家族性高胆固醇血症患儿的冠心病。采用低密度脂蛋白分离术进行最大程度治疗
Internist (Berl). 2003 Apr;44(4):476-80. doi: 10.1007/s00108-002-0832-1.
10
Correction of erythrocyte shape abnormalities in familial hypercholesterolemia after LDL-apheresis: does it influence cerebral hemodynamics?低密度脂蛋白吸附法治疗家族性高胆固醇血症后红细胞形态异常的纠正:这是否会影响脑血流动力学?
Heart Vessels. 1997;12(5):234-40. doi: 10.1007/BF02766789.